HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...

Orchestra BioMed (Nasdaq:OBIO) announced that it received FDA investigational device exemption (IDE) for its Virtue ...

Kestra Medical Technologies today announced the presentation of new real-world data for its Assure wearable cardioverter ...

Sonavex announced that it received FDA 510 (k) clearance for its AI-enabled EchoMap device with 3D ultrasound capabilities.

Medtronic (NYSE: MDT) announced positive primary and secondary outcomes for its VenaSeal spectrum venous leg ulcer (VLU) ...

Symphony Robotics announced that it appointed neurosurgeon Dr. Neil A. Martin as its chief medical officer (CMO).